At a glance
A plain-English guide to how IVF with PGT-A is sometimes considered after recurrent miscarriage, what the testing can and cannot tell you, and the questions worth asking before you commit.
Recurrent miscarriage is usually defined as two or more pregnancy losses, depending on which guideline you follow. When couples search for IVF for recurrent miscarriage in Thailand, they are often trying to answer one question: could embryo testing reduce the chance of another loss? IVF with PGT-A is one option that some clinics discuss, but it is not a guaranteed solution and it is not right for every situation. This guide explains what PGT-A does, how it differs from other embryo tests, where the evidence is uncertain, and how to plan a careful conversation with a clinic in Thailand.
At a glance
- Recurrent miscarriage has many possible causes, and not all of them are chromosomal.
- PGT-A screens embryos for extra or missing chromosomes before transfer.
- PGT-A does not guarantee a pregnancy, a live birth, or a healthy child.
- PGT-M and PGT-SR are different tests used for different reasons.
- IVF itself carries risks and costs, and it does not remove all causes of loss.
- Ask a clinic directly about its own results, criteria, and limitations.
Why recurrent miscarriage happens
Pregnancy loss can result from chromosomal abnormalities in the embryo, structural issues in the uterus, hormonal or metabolic conditions, blood-clotting disorders, infections, immune factors, or a combination of these. In many cases, no single cause is identified even after a full evaluation. Age is one of the strongest factors linked to chromosomal errors in embryos, which is why the chance of loss tends to rise with maternal age.
Because the causes are so varied, no single test or treatment addresses every situation. This is the main reason a careful evaluation usually comes before any decision about IVF or embryo testing.
What PGT-A actually does
PGT-A stands for preimplantation genetic testing for aneuploidy. Aneuploidy means an embryo has an abnormal number of chromosomes. During an IVF cycle, a few cells are removed from an embryo, usually at the blastocyst stage, and those cells are tested in a laboratory. The result is reported as euploid (the expected number of chromosomes), aneuploid (an abnormal number), or sometimes mosaic (a mix of cells with different chromosome numbers).
The purpose of PGT-A is to help select which embryos to transfer. It is a screening test, not a treatment. It does not change the embryo, and it does not fix anything. It simply provides information that a clinician may use when deciding which embryo to transfer first.
PGT-A, PGT-M, and PGT-SR: what is the difference?
| Test | What it looks at | Typical reason it is discussed |
|---|---|---|
| PGT-A | Chromosome number across the embryo | Recurrent miscarriage, advanced maternal age, repeated IVF failure |
| PGT-M | A specific known gene variant | A family history of a single-gene disorder |
| PGT-SR | Chromosome structure, such as a translocation | A known structural chromosome rearrangement in a parent |
These tests are not interchangeable. PGT-A does not detect single-gene disorders, and PGT-M does not screen for aneuploidy across all chromosomes. If you have a known genetic condition in the family, a different test may be more relevant.
How PGT-A is used in recurrent miscarriage
Some miscarriages are caused by chromosomal abnormalities in the embryo, and PGT-A can identify embryos with an abnormal chromosome number before transfer. In theory, transferring only euploid embryos could reduce the chance of miscarriage caused by aneuploidy. In practice, the picture is more complicated.
PGT-A does not prevent miscarriage from other causes, such as uterine problems, clotting disorders, or immune factors. It also does not guarantee that a euploid embryo will implant or develop normally. Some embryos reported as euploid still fail to implant or result in loss, and some mosaic embryos can develop into healthy pregnancies. This is why PGT-A is best understood as one piece of information, not a complete answer.
What the evidence does and does not show
Research on PGT-A has produced mixed results. Some studies suggest a possible reduction in miscarriage rates per transfer, while others show no clear improvement in live birth rates when compared with transferring untested embryos. The evidence is strongest for certain groups, such as women of advanced maternal age, and less clear for others.
Because the evidence is not uniform, professional guidelines generally do not recommend PGT-A as a routine test for everyone with recurrent miscarriage. It is usually presented as an option to discuss, weighing potential benefits against costs, the possibility of having no euploid embryos to transfer, and the chance of a false or uncertain result.
Alternatives and complementary steps
Before or alongside IVF with PGT-A, a clinic may suggest other evaluations. These can include:
- Testing for chromosomal structure in both partners
- Imaging of the uterus to check for structural issues
- Blood tests for thyroid function, diabetes, or clotting disorders
- Review of medications, lifestyle factors, and previous pregnancy records
- Genetic counseling if there is a family history of a known condition
These steps are not alternatives to PGT-A in a strict sense, but they address different possible causes. A complete plan often combines several approaches rather than relying on one test.
Practical questions to ask a clinic in Thailand
When you contact a clinic, ask for clear answers in writing where possible. Useful questions include:
- What is your definition of recurrent miscarriage, and what evaluation do you recommend first?
- Do you offer PGT-A, PGT-M, and PGT-SR, and which would you recommend for my situation?
- What are your laboratory’s typical results for patients with my history?
- What happens if no euploid embryos are available after testing?
- How do you handle mosaic results, and what are the trade-offs?
- What are the total costs, including IVF, testing, medications, and any additional fees?
- What are the success rates for patients with recurrent miscarriage at your clinic, and how are they measured?
- What support is available if the cycle does not result in a pregnancy?
Be cautious of any clinic that promises a specific outcome or presents PGT-A as a guaranteed solution. No test can promise a healthy baby.
Planning and next steps
If you are considering IVF for recurrent miscarriage in Thailand, a sensible sequence is:
- Gather your previous medical records, including any miscarriage testing or imaging.
- Ask for a full evaluation of possible causes before committing to IVF.
- Discuss whether PGT-A is likely to change your management, and how.
- Ask about costs, timelines, and what happens if testing leaves no embryos to transfer.
- Consider a second opinion if the advice feels rushed or overly certain.
- Confirm visa, travel, and legal requirements with the relevant authorities, as these can change.
For more background, see our pages on PGT in Thailand, our patient guides, and our frequently asked questions.
Frequently asked questions
Does PGT-A prevent miscarriage?
No. PGT-A can identify embryos with an abnormal number of chromosomes, which is one possible cause of miscarriage. It does not prevent miscarriage from other causes, and it cannot guarantee that a transferred embryo will implant or develop into a healthy pregnancy.
Is PGT-A recommended for everyone with recurrent miscarriage?
No. Professional guidelines generally do not recommend PGT-A as a routine test for all cases of recurrent miscarriage. It is usually discussed as an option, and the decision depends on your history, age, previous test results, and personal preferences.
What is the difference between PGT-A and PGT-M?
PGT-A screens for an abnormal number of chromosomes across the embryo. PGT-M looks for a specific gene variant that is known to run in a family. They are used for different reasons and are not interchangeable.
What happens if no embryos are suitable for transfer after PGT-A?
This is a possible outcome. If testing shows that no embryos are suitable, the cycle may end without a transfer. Ask your clinic in advance how they handle this situation and what options, including counseling and financial considerations, are available.
Can I have IVF with PGT-A in Thailand if I am an international patient?
Many clinics in Thailand accept international patients, but availability, requirements, and costs vary. You should confirm details directly with the clinic and check current travel and legal requirements with the relevant authorities before making plans.
Continue your research
Medical information notice: This article is educational and does not replace individual assessment, diagnosis, genetic counselling or treatment advice from a licensed clinician. Provider services, availability, fees and policies should be verified directly before booking.
Need help turning research into a shortlist?
